About Idenix

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, MA, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases. Idenix's current focus is on the treatment of infections caused by hepatitis C virus (HCV).

The company believes that maintaining a full pipeline of drug candidates with the potential to become first- or best-in-class therapies for large and growing markets is critical to its long-term growth and success. Idenix seeks to optimize the value of new drug candidates through efficient, rapid and market-driven clinical development programs. Today, Idenix has a robust pipeline focused on agents that it believes will advance the treatment of hepatitis C.